Resultado da Busca
Há 4 dias · Michael Goldsworthy. www.silex.com.au. Silex Systems Limited, a technology commercialization company, engages in the research and development, commercialization, and license of SILEX laser enrichment technology in Australia. It operates through three segments: Silex Systems, Translucent, and Silex USA.
Há 4 dias · Michael Goldsworthy Sold 67,688 shares Total: $240,969.28 ($3.56/share) SLX Stock Analysis - Frequently Asked Questions How were Silex Systems' earnings last quarter?
Há 4 dias · Silex Systems Limited is a technology commercialization company. The Company is focused on the commercialization of its Separation of Isotopes by Laser EXcitation (SILEX) laser enrichment technology for application to uranium production and enrichment (nuclear power), silicon enrichment (silicon quantum computing) and medical isotope enrichment (new cancer therapies).
Há 4 dias · Silex Systems Limited ist ein Unternehmen, das Technologien vermarktet. Das Unternehmen konzentriert sich auf die Kommerzialisierung seiner Laseranreicherungstechnologie Separation of Isotopes by Laser EXcitation (SILEX) für Anwendungen in den Bereichen Uranproduktion und -anreicherung (Kernkraft), Siliziumanreicherung (Silizium-Quantencomputer) und medizinische Isotopenanreicherung (neue ...
- SILEX SYSTEMS LIMITED
Há 3 dias · Retrouvez la répartition par types d'actionnaires de Silex Systems Limited cotée à la bourse de BOERSE MUENCHEN. Découvrez l'origine géographique des actionnaires de Silex Systems Limited
Há 1 dia · Michael Duane Johnson (born September 13, 1967) is an American retired sprinter who became Olympic Champion four times, and World Champion eight times in the span of his career. [2] He held the world and Olympic records in the 200 m and 400 m , as well as the world record in the indoor 400 m.
Há 2 dias · The “exposome,” a term coined by cancer biologist Christopher P. Wild in 2005, 10 encompasses the myriad environmental factors to which an individual is exposed throughout life. Notably, a growing body of evidence highlights the role of the early life exposome in setting the stage for disease risk later in life.
